Here are five takeaways:
1. The shares were purchased at an average price of $5.06 per share, for a total value of $101,200.
2. The CEO now owns 753,250 shares of the company’s stock.
3. EndoChoice has a 52-week low of $3.70 and a 52-week high of $19.69.
4. The company’s 50-day moving average price is $4.81 and its 200-day moving average price is $8.81.
5. The company’s market capitalization is $143.81 million.
More articles on GI/endoscopy:
6 GI physicians in the news — March 18, 2016
Drs. Paul Fishbein, Vicente Lago join Gastro Health — 3 highlights
GI physician leader to know: Dr. Paul Lebovitz of Allegheny Health Network
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
